Atlas Trials

Topical Everolimus in Patients With Tuberous Sclerosis Complex

Clinical trial NCT02860494 · WITHDRAWN

Trial details

NCT number
NCT02860494
Sponsor
Hospices Civils de Lyon
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Facial Angiofibromas
Start date
2020-12-01
Primary completion
2023-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.